Press "Enter" to skip to content

New technology is letting us edit humanity, but should we? | Jeffrey Kahn | TEDxMidAtlantic


[Music]

[Music] behind me is a cartoon of a developing

behind me is a cartoon of a developing

behind me is a cartoon of a developing human embryo until the really recent

human embryo until the really recent

human embryo until the really recent last few weeks an embryo could survive

last few weeks an embryo could survive

last few weeks an embryo could survive outside the human body only until about

outside the human body only until about

outside the human body only until about the fourteenth day so it could divide so

the fourteenth day so it could divide so

the fourteenth day so it could divide so called in vitro in a test tube in a

called in vitro in a test tube in a

called in vitro in a test tube in a laboratory up to the point of two weeks

laboratory up to the point of two weeks

laboratory up to the point of two weeks and at two weeks tissues start to

and at two weeks tissues start to

and at two weeks tissues start to differentiate and so that became the

differentiate and so that became the

differentiate and so that became the standard the policy that the rule by

standard the policy that the rule by

standard the policy that the rule by which the world agreed to allow human

which the world agreed to allow human

which the world agreed to allow human embryos to grow outside the human body

embryos to grow outside the human body

embryos to grow outside the human body 14 days and the map of the world and the

14 days and the map of the world and the

14 days and the map of the world and the regulations around what could be

regulations around what could be

regulations around what could be permitted looked like this

the rule was created by the limits of

the rule was created by the limits of technology plus what we took to be a

technology plus what we took to be a

technology plus what we took to be a moral boundary as an embryo begins to

moral boundary as an embryo begins to

moral boundary as an embryo begins to divide to the point where tissues start

divide to the point where tissues start

divide to the point where tissues start to differentiate maybe there’s something

to differentiate maybe there’s something

to differentiate maybe there’s something different about that outside the body

different about that outside the body

different about that outside the body and we shouldn’t allow it to go further

and we shouldn’t allow it to go further

and we shouldn’t allow it to go further that was the case policy around the

that was the case policy around the

that was the case policy around the world international consensus until this

world international consensus until this

world international consensus until this year until 2016 when two groups were

year until 2016 when two groups were

year until 2016 when two groups were able to grow embryos past that 14-day

able to grow embryos past that 14-day

able to grow embryos past that 14-day limit outside of the body and so calls

limit outside of the body and so calls

limit outside of the body and so calls have been in the literature for

have been in the literature for

have been in the literature for extending the 14-day limit why should we

extending the 14-day limit why should we

extending the 14-day limit why should we stop when technology allows us to go

stop when technology allows us to go

stop when technology allows us to go further lots of science can be learned

further lots of science can be learned

further lots of science can be learned lots of advantage for how we treat

lots of advantage for how we treat

lots of advantage for how we treat couples who have infertility could be

couples who have infertility could be

couples who have infertility could be had by going past that 14-day limit but

had by going past that 14-day limit but

had by going past that 14-day limit but what is the morality of growing embryos

what is the morality of growing embryos

what is the morality of growing embryos past the point of tissues beginning to

past the point of tissues beginning to

past the point of tissues beginning to differentiate so there’s no longer a

differentiate so there’s no longer a

differentiate so there’s no longer a technological boundary

technological boundary

technological boundary and we didn’t really create a hard moral

and we didn’t really create a hard moral

and we didn’t really create a hard moral boundary and so we’re in the point of

boundary and so we’re in the point of

boundary and so we’re in the point of our history related to embryo research

our history related to embryo research

our history related to embryo research where there really isn’t a clear rule

here’s a photograph of a human embryo so

here’s a photograph of a human embryo so I showed you a cartoon a minute ago this

I showed you a cartoon a minute ago this

I showed you a cartoon a minute ago this is actually a highly magnified

is actually a highly magnified

is actually a highly magnified photograph of a three-day-old

photograph of a three-day-old

photograph of a three-day-old embryo just a few divisions after

embryo just a few divisions after

embryo just a few divisions after fertilization egg and sperm come

fertilization egg and sperm come

fertilization egg and sperm come together that makes one divides once

together that makes one divides once

together that makes one divides once into two twice into four one more time

into two twice into four one more time

into two twice into four one more time into eight that’s an eight-cell embryo

into eight that’s an eight-cell embryo

into eight that’s an eight-cell embryo behind me about three days after

behind me about three days after

behind me about three days after fertilization it’s being held by that

fertilization it’s being held by that

fertilization it’s being held by that red pipette in place so that the smaller

red pipette in place so that the smaller

red pipette in place so that the smaller pipette can be inserted and a single

pipette can be inserted and a single

pipette can be inserted and a single cell removed from that developing embryo

cell removed from that developing embryo

cell removed from that developing embryo this is called pre-implantation genetic

this is called pre-implantation genetic

this is called pre-implantation genetic diagnosis it’s a biopsy effectively of a

diagnosis it’s a biopsy effectively of a

diagnosis it’s a biopsy effectively of a very early stage embryo again in vitro

very early stage embryo again in vitro

very early stage embryo again in vitro outside of the body what’s the point

outside of the body what’s the point

outside of the body what’s the point this can be used and has been used again

this can be used and has been used again

this can be used and has been used again since the 1990s in this case to do

since the 1990s in this case to do

since the 1990s in this case to do genetic testing of an embryo prior to

genetic testing of an embryo prior to

genetic testing of an embryo prior to implanting it into a woman’s body to

implanting it into a woman’s body to

implanting it into a woman’s body to identify the embryos that might be

identify the embryos that might be

identify the embryos that might be diseased and avoid implanting those used

diseased and avoid implanting those used

diseased and avoid implanting those used very widely for families that know that

very widely for families that know that

very widely for families that know that they’re at risk of passing on diseases

they’re at risk of passing on diseases

they’re at risk of passing on diseases like cystic fibrosis and so that’s what

like cystic fibrosis and so that’s what

like cystic fibrosis and so that’s what it was used for in the late 80s until

it was used for in the late 80s until

it was used for in the late 80s until the middle late 1990s because we didn’t

the middle late 1990s because we didn’t

the middle late 1990s because we didn’t really think about other kinds of

really think about other kinds of

really think about other kinds of applications create embryos in the

applications create embryos in the

applications create embryos in the laboratory by in-vitro fertilization and

laboratory by in-vitro fertilization and

laboratory by in-vitro fertilization and then test them and decide which ones to

then test them and decide which ones to

then test them and decide which ones to put in you are identifying some of the

put in you are identifying some of the

put in you are identifying some of the disease characteristics in embryos and

disease characteristics in embryos and

disease characteristics in embryos and implanting only those that are free of

implanting only those that are free of

implanting only those that are free of that disease not changing anything just

that disease not changing anything just

that disease not changing anything just identifying what’s there so the limits

identifying what’s there so the limits

identifying what’s there so the limits of our ability to think pass what the

of our ability to think pass what the

of our ability to think pass what the use of that technology could be put to

use of that technology could be put to

use of that technology could be put to the limits of our ingenuity really

the limits of our ingenuity really

the limits of our ingenuity really created a rule of sorts fast forward

created a rule of sorts fast forward

created a rule of sorts fast forward a family in Minnesota by the name of

a family in Minnesota by the name of

a family in Minnesota by the name of Jack and Lisa Nash had a child his name

Jack and Lisa Nash had a child his name

Jack and Lisa Nash had a child his name is Molly Molly is sitting in her parents

is Molly Molly is sitting in her parents

is Molly Molly is sitting in her parents lap there Molly suffers from something

lap there Molly suffers from something

lap there Molly suffers from something called Fanconi anemia passed to her by

called Fanconi anemia passed to her by

called Fanconi anemia passed to her by both of her parents parents are carriers

both of her parents parents are carriers

both of her parents parents are carriers of that disease mutation but they don’t

of that disease mutation but they don’t

of that disease mutation but they don’t have it they both passed on that

have it they both passed on that

have it they both passed on that mutation to their first child Molly and

mutation to their first child Molly and

mutation to their first child Molly and she was born with that disease that

she was born with that disease that

she was born with that disease that disease caused her to have leukemia at

disease caused her to have leukemia at

disease caused her to have leukemia at the age of seven years old you see her

the age of seven years old you see her

the age of seven years old you see her behind me she’s at seven years old

behind me she’s at seven years old

behind me she’s at seven years old sitting at the Mall of America what was

sitting at the Mall of America what was

sitting at the Mall of America what was then called Camp Snoopy now now called I

then called Camp Snoopy now now called I

then called Camp Snoopy now now called I think Sponge Bob Squarepants Park or

think Sponge Bob Squarepants Park or

think Sponge Bob Squarepants Park or something to that effect

they decided to use the technique I

they decided to use the technique I showed you before pre-implantation

showed you before pre-implantation

showed you before pre-implantation genetic diagnosis to identify embryos

genetic diagnosis to identify embryos

genetic diagnosis to identify embryos that didn’t have the same genetic

that didn’t have the same genetic

that didn’t have the same genetic disease as their daughter Molly and they

disease as their daughter Molly and they

disease as their daughter Molly and they did that so that they would implant an

did that so that they would implant an

did that so that they would implant an embryo for their next that would become

embryo for their next that would become

embryo for their next that would become their next child that wouldn’t have that

their next child that wouldn’t have that

their next child that wouldn’t have that disease but they did one more thing this

disease but they did one more thing this

disease but they did one more thing this is where the ingenuity came in they said

is where the ingenuity came in they said

is where the ingenuity came in they said as long as we’re doing that avoiding our

as long as we’re doing that avoiding our

as long as we’re doing that avoiding our next child having this disease let’s

next child having this disease let’s

next child having this disease let’s make sure that that child could also

make sure that that child could also

make sure that that child could also help save our daughter’s life so they

help save our daughter’s life so they

help save our daughter’s life so they did a genetic test on the embryos that

did a genetic test on the embryos that

did a genetic test on the embryos that were negative for that disease to see

were negative for that disease to see

were negative for that disease to see which ones were genetic match to their

which ones were genetic match to their

which ones were genetic match to their daughter Molly

daughter Molly

daughter Molly so the cord blood from that baby could

so the cord blood from that baby could

so the cord blood from that baby could be used to transfuse Molly and cure her

be used to transfuse Molly and cure her

be used to transfuse Molly and cure her of her leukemia so a stem cell

of her leukemia so a stem cell

of her leukemia so a stem cell transplant from the umbilical cord blood

transplant from the umbilical cord blood

transplant from the umbilical cord blood of the baby that was born from that

of the baby that was born from that

of the baby that was born from that technique that baby is sitting in

technique that baby is sitting in

technique that baby is sitting in Molly’s lap and his name I kid you not

Molly’s lap and his name I kid you not

Molly’s lap and his name I kid you not is Adam Adam Nash here’s a picture of

is Adam Adam Nash here’s a picture of

is Adam Adam Nash here’s a picture of Molly and Adam together back home in

Molly and Adam together back home in

Molly and Adam together back home in Denver Colorado where they now live

Denver Colorado where they now live

Denver Colorado where they now live quite happily ever after it’s happened

quite happily ever after it’s happened

quite happily ever after it’s happened in 1999 and 2000 it’s made into a book

in 1999 and 2000 it’s made into a book

in 1999 and 2000 it’s made into a book which many of you I’m sure have read all

which many of you I’m sure have read all

which many of you I’m sure have read all my sister’s keeper a little different

my sister’s keeper a little different

my sister’s keeper a little different outcome in the book if you’ve read it

outcome in the book if you’ve read it

outcome in the book if you’ve read it made into a not-so-great movie

made into a not-so-great movie

made into a not-so-great movie the point is turn into a novel but based

the point is turn into a novel but based

the point is turn into a novel but based on a true account in the book I’ll ruin

on a true account in the book I’ll ruin

on a true account in the book I’ll ruin it for you there are two daughters

it for you there are two daughters

it for you there are two daughters rather than a daughter and a son and the

rather than a daughter and a son and the

rather than a daughter and a son and the the younger daughter becomes a parts

the younger daughter becomes a parts

the younger daughter becomes a parts factory for her older sister not what

factory for her older sister not what

factory for her older sister not what happened in the Nash case but one could

happened in the Nash case but one could

happened in the Nash case but one could see that going forward so never

see that going forward so never

see that going forward so never underestimate human ingenuity and we

underestimate human ingenuity and we

underestimate human ingenuity and we need to make rules so that we allow the

need to make rules so that we allow the

need to make rules so that we allow the good kinds of human ingenuity but not

good kinds of human ingenuity but not

good kinds of human ingenuity but not the ethically questionable applications

making policy so how do we do this there

making policy so how do we do this there are real problems in making policy

are real problems in making policy

are real problems in making policy around cases like this because we have a

around cases like this because we have a

around cases like this because we have a ban in this country

ban in this country

ban in this country on the use of any federal funding any

on the use of any federal funding any

on the use of any federal funding any dollars from us as taxpayers that is

dollars from us as taxpayers that is

dollars from us as taxpayers that is used in research that causes harm or

used in research that causes harm or

used in research that causes harm or destroys a human embryo which seemed

destroys a human embryo which seemed

destroys a human embryo which seemed like a reasonable policy born out of the

like a reasonable policy born out of the

like a reasonable policy born out of the abortion debates of the 1970s and

abortion debates of the 1970s and

abortion debates of the 1970s and avoiding what’s called sometimes the

avoiding what’s called sometimes the

avoiding what’s called sometimes the dirty hands problem I don’t want my

dirty hands problem I don’t want my

dirty hands problem I don’t want my money being used in ways that I deemed

money being used in ways that I deemed

money being used in ways that I deemed to be ethically unacceptable so to avoid

to be ethically unacceptable so to avoid

to be ethically unacceptable so to avoid that problem we just don’t allow

that problem we just don’t allow

that problem we just don’t allow taxpayer dollars to be used in research

taxpayer dollars to be used in research

taxpayer dollars to be used in research like that it’s had an effect of not

like that it’s had an effect of not

like that it’s had an effect of not allowing us to do much research in human

allowing us to do much research in human

allowing us to do much research in human developmental biology so we don’t learn

developmental biology so we don’t learn

developmental biology so we don’t learn things we otherwise might but at the

things we otherwise might but at the

things we otherwise might but at the same time it it doesn’t allow us to

same time it it doesn’t allow us to

same time it it doesn’t allow us to control the science because in this

control the science because in this

control the science because in this country somewhat unusually with research

country somewhat unusually with research

country somewhat unusually with research dollars come research rules and when you

dollars come research rules and when you

dollars come research rules and when you do things with private money you don’t

do things with private money you don’t

do things with private money you don’t have to follow those research rules so

have to follow those research rules so

have to follow those research rules so we have all sorts of challenges when it

we have all sorts of challenges when it

we have all sorts of challenges when it comes to not only how we fund research

comes to not only how we fund research

comes to not only how we fund research but how we fund applications like the

but how we fund applications like the

but how we fund applications like the ones I just mentioned to you

ones I just mentioned to you

ones I just mentioned to you turns out the Nashes had to pay for that

turns out the Nashes had to pay for that

turns out the Nashes had to pay for that all out-of-pocket and that’s because in

all out-of-pocket and that’s because in

all out-of-pocket and that’s because in most states in this country the

most states in this country the

most states in this country the insurance policies don’t cover IVF and

insurance policies don’t cover IVF and

insurance policies don’t cover IVF and they certainly don’t cover it for uses

they certainly don’t cover it for uses

they certainly don’t cover it for uses like the Nash’s put it too and so when

like the Nash’s put it too and so when

like the Nash’s put it too and so when there’s not third-party payer oversight

there’s not third-party payer oversight

there’s not third-party payer oversight they’re not rules made about what’s

they’re not rules made about what’s

they’re not rules made about what’s acceptable and what’s not all of this

acceptable and what’s not all of this

acceptable and what’s not all of this plays into the stem cell research debate

plays into the stem cell research debate

plays into the stem cell research debate we’ve been having and leads us to this

we’ve been having and leads us to this

we’ve been having and leads us to this problem right it’s a kind of perfect

problem right it’s a kind of perfect

problem right it’s a kind of perfect storm we don’t have rules and we’ve got

storm we don’t have rules and we’ve got

storm we don’t have rules and we’ve got strong incentives to do things to get

strong incentives to do things to get

strong incentives to do things to get around whatever rules there might be

around whatever rules there might be

around whatever rules there might be move forward this is very recent science

move forward this is very recent science

move forward this is very recent science it’s a cartoon that will be very hard

it’s a cartoon that will be very hard

it’s a cartoon that will be very hard for you to see the point of it is for

for you to see the point of it is for

for you to see the point of it is for women who have something called

women who have something called

women who have something called mitochondrial DNA disease they pass on

mitochondrial DNA disease they pass on

mitochondrial DNA disease they pass on very severe genetic illness not in the

very severe genetic illness not in the

very severe genetic illness not in the nuclear part of their genome if you

nuclear part of their genome if you

nuclear part of their genome if you think of it as a chicken egg not in the

think of it as a chicken egg not in the

think of it as a chicken egg not in the yellow part in the yolk but turns out

yellow part in the yolk but turns out

yellow part in the yolk but turns out there’s a little bit of DNA in the white

there’s a little bit of DNA in the white

there’s a little bit of DNA in the white part in the cytoplasm

part in the cytoplasm

part in the cytoplasm it’s called mitochondrial DNA

it’s called mitochondrial DNA

it’s called mitochondrial DNA mitochondria make energy for our cell

mitochondria make energy for our cell

mitochondria make energy for our cell and so for women who have mitochondrial

and so for women who have mitochondrial

and so for women who have mitochondrial DNA disease mutations the only kinds of

DNA disease mutations the only kinds of

DNA disease mutations the only kinds of offspring they can have will be kids who

offspring they can have will be kids who

offspring they can have will be kids who have those kind of mitochondrial DNA

have those kind of mitochondrial DNA

have those kind of mitochondrial DNA diseases and so to combat that people

diseases and so to combat that people

diseases and so to combat that people have figured out through again very

have figured out through again very

have figured out through again very fancy manipulation of eggs or embryos

fancy manipulation of eggs or embryos

fancy manipulation of eggs or embryos taking the donor cytoplasm and taking

taking the donor cytoplasm and taking

taking the donor cytoplasm and taking the DNA from the woman who’s got nuclear

the DNA from the woman who’s got nuclear

the DNA from the woman who’s got nuclear DNA the woman who’s got the

DNA the woman who’s got the

DNA the woman who’s got the mitochondrial disease and putting them

mitochondrial disease and putting them

mitochondrial disease and putting them together so DNA from two women

together so DNA from two women

together so DNA from two women effectively nuclear DNA from the woman

effectively nuclear DNA from the woman

effectively nuclear DNA from the woman who wants to be the mother cytoplasmic

who wants to be the mother cytoplasmic

who wants to be the mother cytoplasmic of mitochondrial DNA from the woman

of mitochondrial DNA from the woman

of mitochondrial DNA from the woman who’s a donor putting that together

who’s a donor putting that together

who’s a donor putting that together sperm from the man and you get an embryo

sperm from the man and you get an embryo

sperm from the man and you get an embryo the problem is you’ve also got DNA from

the problem is you’ve also got DNA from

the problem is you’ve also got DNA from two women and one man never before in

two women and one man never before in

two women and one man never before in human history has that been possible and

human history has that been possible and

human history has that been possible and not only are you manipulating changing

not only are you manipulating changing

not only are you manipulating changing the DNA of that offspring but those

the DNA of that offspring but those

the DNA of that offspring but those changes will be inherited by future

changes will be inherited by future

changes will be inherited by future generations we’re making changes in the

generations we’re making changes in the

generations we’re making changes in the germ line which has been a boundary a

germ line which has been a boundary a

germ line which has been a boundary a barrier again posed by technology but

barrier again posed by technology but

barrier again posed by technology but now there is no boundary the FDA in this

now there is no boundary the FDA in this

now there is no boundary the FDA in this country the Food and Drug Administration

country the Food and Drug Administration

country the Food and Drug Administration which oversees controls new drugs

which oversees controls new drugs

which oversees controls new drugs devices biologics has said that they

devices biologics has said that they

devices biologics has said that they were willing to accept proposals for

were willing to accept proposals for

were willing to accept proposals for licensing this technology under very

licensing this technology under very

licensing this technology under very strict rules the Congress prohibited

strict rules the Congress prohibited

strict rules the Congress prohibited that from happening in its last budget

that from happening in its last budget

that from happening in its last budget bill FDA may not receive such license

bill FDA may not receive such license

bill FDA may not receive such license applications because it was deemed to be

applications because it was deemed to be

applications because it was deemed to be creation of an embryo that would have

creation of an embryo that would have

creation of an embryo that would have heritable genetic change germline change

heritable genetic change germline change

heritable genetic change germline change not acceptable so the lesson from this

not acceptable so the lesson from this

not acceptable so the lesson from this as you’ll see in a second is that a

as you’ll see in a second is that a

as you’ll see in a second is that a prohibition like that may seem like a

prohibition like that may seem like a

prohibition like that may seem like a strong rule but in fact is more like no

strong rule but in fact is more like no

strong rule but in fact is more like no rule at all just announced in the last

rule at all just announced in the last

rule at all just announced in the last few weeks baby born in Mexico American

few weeks baby born in Mexico American

few weeks baby born in Mexico American scientists went to Guadalajara to do the

scientists went to Guadalajara to do the

scientists went to Guadalajara to do the technique that I just showed you why

technique that I just showed you why

technique that I just showed you why because as it says on the slide behind

because as it says on the slide behind

because as it says on the slide behind me there are no rules

me there are no rules

me there are no rules in Mexico so we went there to avoid

in Mexico so we went there to avoid

in Mexico so we went there to avoid their prohibition in the United States

their prohibition in the United States

their prohibition in the United States prohibition

prohibition

prohibition pushed people to go abroad you might say

pushed people to go abroad you might say

pushed people to go abroad you might say well that’s not such a big deal there’s

well that’s not such a big deal there’s

well that’s not such a big deal there’s a very few women in the world who have

a very few women in the world who have

a very few women in the world who have mitochondrial DNA disease announced even

mitochondrial DNA disease announced even

mitochondrial DNA disease announced even more recently to women in Kiev use this

more recently to women in Kiev use this

more recently to women in Kiev use this technique not for mitochondrial DNA

technique not for mitochondrial DNA

technique not for mitochondrial DNA disease but because they had advanced

disease but because they had advanced

disease but because they had advanced maternal age couldn’t get pregnant they

maternal age couldn’t get pregnant they

maternal age couldn’t get pregnant they were infertile use this technique to

were infertile use this technique to

were infertile use this technique to boost their ability to have children

boost their ability to have children

boost their ability to have children many many more women in the world might

many many more women in the world might

many many more women in the world might opt for that so prohibitions or bans

opt for that so prohibitions or bans

opt for that so prohibitions or bans sometimes push people to avoid the rules

lastly set of techniques technologies

lastly set of techniques technologies CRISPR Cassadine is one that’s been in

CRISPR Cassadine is one that’s been in

CRISPR Cassadine is one that’s been in the news a lot tail ins is another zinc

the news a lot tail ins is another zinc

the news a lot tail ins is another zinc finger technology these are all tools to

finger technology these are all tools to

finger technology these are all tools to edit our genetic makeup not test for it

edit our genetic makeup not test for it

edit our genetic makeup not test for it but edit it change it editing our

but edit it change it editing our

but edit it change it editing our humanity what makes us human the traits

humanity what makes us human the traits

humanity what makes us human the traits that we carry just announced in the last

that we carry just announced in the last

that we carry just announced in the last few weeks that a researcher at the

few weeks that a researcher at the

few weeks that a researcher at the Karolinska Institute in Sweden used

Karolinska Institute in Sweden used

Karolinska Institute in Sweden used CRISPR one of these techniques to modify

CRISPR one of these techniques to modify

CRISPR one of these techniques to modify human embryos never had been done in a

human embryos never had been done in a

human embryos never had been done in a viable human embryo only have been done

viable human embryo only have been done

viable human embryo only have been done in non viable human embryos up to that

in non viable human embryos up to that

in non viable human embryos up to that point Nature premier journal asked a

point Nature premier journal asked a

point Nature premier journal asked a question about whether it was time for

question about whether it was time for

question about whether it was time for another Asilomar Asilomar is a very

another Asilomar Asilomar is a very

another Asilomar Asilomar is a very famous conference in the world of

famous conference in the world of

famous conference in the world of science policy where the first

science policy where the first

science policy where the first recombinant DNA techniques were

recombinant DNA techniques were

recombinant DNA techniques were discussed in the 1970s and the

discussed in the 1970s and the

discussed in the 1970s and the scientific community said we will not do

scientific community said we will not do

scientific community said we will not do certain things by consensus agreement of

certain things by consensus agreement of

certain things by consensus agreement of the professionals it won’t work

the professionals it won’t work

the professionals it won’t work today in 2016 the scientific community

today in 2016 the scientific community

today in 2016 the scientific community is too diverse too broad and too

is too diverse too broad and too

is too diverse too broad and too democratic bentos a company

democratic bentos a company

democratic bentos a company that offers you portable over the web

that offers you portable over the web

that offers you portable over the web hits to do genetic technology sometimes

hits to do genetic technology sometimes

hits to do genetic technology sometimes called garage science so where are we

called garage science so where are we

called garage science so where are we the new biology as I’ve talked about

the new biology as I’ve talked about

the new biology as I’ve talked about requires new rules it’s time to start

requires new rules it’s time to start

requires new rules it’s time to start making them thanks

making them thanks

making them thanks [Applause]

”

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *